Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7d3615c185ee02118f7bc2a45482928 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b3dcaaf8f814508f0c70b57d743c361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e12332a8bb1773fed8ec2b3f245766 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
1996-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0344968414723a9eebc8915eef97102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_678d26559fbd339b1ddf3f7eed6609f8 |
publicationDate |
1997-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9714037-A1 |
titleOfInvention |
Determination and monitoring of bladder cancer |
abstract |
A test method for determination of the presence of bladder cancer by determination of the urinary gonadotropin peptide (UGP) levels in no-blood body fluids is described. The method can also be used to monitor the course of bladder cancer and its treatment and the reoccurrance of the disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9855656-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9851824-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6949357-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9902734-A1 |
priorityDate |
1995-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |